Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Dimensions has found 13 publications that cite this research output.

Article in Frontiers in Immunology (August 2024)

Article in Clinical and Translational Oncology (April 2024)

Article in Pharmacology & Therapeutics (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.